Bacteria |
Easy to manipulate |
Improper folding |
Low cost |
Endotoxin accumulation |
High expression |
|
Existing regulatory approval |
|
Mammalian cells |
Proper folding |
High production cost |
High yields |
Risk of human pathogen contamination |
Existing regulatory approval |
Expensive media |
Yeast |
Rapid growth and scalable |
Difficulty in cell disruption |
Easy to manipulate |
Limited glycosylation capacity |
Scalable |
|
Existing regulatory approval |
|
Insect cells |
High expression levels |
High cost and time consuming |
Proper folding |
Expensive media |
Scalable |
Nonhuman glycosylation |
Plant |
Less pathogen and bacterial toxin contamination |
Regulatory compliance |
Economical |
Limited glycosylation capacity |